Skip to main content
. Author manuscript; available in PMC: 2012 Mar 10.
Published in final edited form as: J Med Chem. 2011 Feb 14;54(5):1126–1139. doi: 10.1021/jm100912b

Figure 4.

Figure 4

Initial evaluation of compounds 1 and 12-32 against rPIV5-RL at one day post infection. All compounds were tested at 1 μM. Compounds comparable in activity to 1 were further examined at 0.5 μM (concentrations (μM) shown in brackets). Error bars represent standard errors of the mean.